Platelet and soluble CD40L in meningococcal sepsis

Intensive Care Medicine

Volumn 32, Issue 9, 2006, Pages 1432-1437

  Inwald, David P ^a   Faust, Saul N ^b   Lister, Paula ^c   Peters, Mark J ^c   Levin, Michael ^a   Heyderman, Robert ^d   Klein, Nigel J ^c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

CD40L; Inflammation; Meningococcus; Platelets; Sepsis; Thrombosis

Indexed keywords

CD40 LIGAND; PADGEM PROTEIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; INFLAMMATION; INTENSIVE CARE; MEMBRANE BINDING; MENINGOCOCCEMIA; PRESCHOOL CHILD; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SEPSIS; SKIN BIOPSY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS;

CASE-CONTROL STUDIES; CD40 LIGAND; CHILD; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MENINGOCOCCAL INFECTIONS; PLATELET COUNT; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 33747609087     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-006-0250-2     Document Type: Article

References (30)

1. Hawrylowicz CM, Howells GL, Feldmann M (1991) Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production. J Exp Med 174:785-790
2. McEver RP (2001) Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation. Thromb Haemost 86:746-756
3. Peters MJ, Heyderman RS, Faust S, Dixon GL, Inwald DP, Klein NJ (2003) Severe meningococcal disease is characterized by early neutrophil but not platelet activation and increased formation and consumption of platelet-neutrophil complexes. J Leukoc Biol 73:722-730
4. Peters MJ, Ross-Russell RI, White D, Kerr SJ, Eaton FR, Keengwe IN, Tasker RC, Wade A, Klein NJ (2001) Early severe neutropenia and thrombocytopenia identifies the highest risk cases of severe meningococcal disease. Ped Crit Care Med 2:225-231
5. Sotto MN, Langer B, Hoshino-Shimizu S, de Brito T (1976) Pathogenesis of cutaneous lesions in acute meningococcemia in humans: light, immunofluorescent, and electron microscopic studies of skin biopsy specimens. J Infect Dis 133:506-514
6. Faust SN, Levin M, Harrison OB, Goldin RD, Lockhart MS, Kondaveeti S, Laszik Z, Esmon CT, Heyderman RS (2001) Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl Med 345:408-416
7. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, Kroczek RA (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591-594
8. Henn V, Steinbach S, Buchner K, Presek P, Kroczek RA (2001) The inflammatory reaction of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 98:1047-1054
9. Korthauer U, Graf D, Mages HW, Briere F, Padayachee M, Malcolm S, Ugazio AG, Notarangelo LD, Levinsky RJ, Kroczek RA (1993) Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361:539-541
10. Scott MJ, Hoth JJ, Stagner MK, Gardner SA, Peyton JC, Cheadle WG (2004) CD40-CD154 interactions between macrophages and natural killer cells during sepsis are critical for macrophage activation and are not interferon gamma dependent. Clin Exp Immunol 137:469-477
11. Slupsky JR, Kalbas M, Willuweit A, Henn V, Kroczek RA, Muller-Berghaus G (1998) Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40. Thromb Haemost 80:1008-1014
12. Lindmark E, Tenno T, Siegbahn A (2000) Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression. Arterioscler Thromb Vasc Biol 20:2322-2328
13. Amirkhosravi A, Amaya M, Desai H, Francis JL (2002) Platelet-CD40 ligand interaction with melanoma cell and monocyte CD40 enhances cellular procoagulant activity. Blood Coagul Fibrinolysis 13:505-512
14. Tanaka T, Kuroiwa T, Ikeuchi H, Ota F, Kaneko Y, Ueki K, Tsukada Y, McInnes IB, Boumpas DT, Nojima Y (2002) Human platelets stimulate mesangial cells to produce MCP-1 via the CD40/CD40 ligand pathway and may amplify glomerular injury. J Am Soc Nephrol 13:2488-2496
15. Andre P, Prasad KS, Denis CV, He M, Papalia JM, Hynes RO, Phillips DR, Wagner DD (2002) CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat Med 8:247-252
16. Prasad KS, Andre P, He M, Bao M, Manganello J, Phillips DR (2003) Soluble CD40 ligand induces beta3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling. Proc Natl Acad Sci USA 100:12367-12371
17. Inwald DP, McDowall A, Peters MJ, Callard RE, Klein NJ (2003) CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 92:1041-1048
18. Andre P, Nannizzi-Alaimo L, Prasad SK, Phillips DR (2002) Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 106:896-899
19. Schwabe RF, Engelmann H, Hess S, Fricke H (1999) Soluble CD40 in the serum of healthy donors, patients with chronic renal failure, haemodialysis and chronic ambulatory peritoneal dialysis (CAPD) patients. Clin Exp Immunol 117:153-158
20. Inwald DP, Kirkham FJ, Peters MJ, Lane R, Wade A, Evans JP, Klein NJ (2000) Platelet and leucocyte activation in childhood sickle cell disease: association with nocturnal hypoxaemia. Br J Haematol 111:474-481
21. Kato K, Santana-Sahagun E, Rassenti LZ, Weisman MH, Tamura N, Kobayashi S, Hashimoto H, Kipps TJ (1999) The soluble CD40 ligand sCD154 in systemic lupus erythematosus. J Clin Invest 104:947-955
22. Heeschen C, Dimmeler S, Hamm CW, van den Brand MJ, Boersma E, Zeiher AM, Simoons ML (2003) Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 348:1104-1111
23. Wang CL, Wu YT, Liu CA, Lin MW, Lee CJ, Huang LT, Yang KD (2003) Expression of CD40 ligand on CD4+ T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease. Pediatrics 111:E140-E147
24. Pollack MM, Patel KM, Ruttimann UE (1996) PRISM III: an updated Pediatric Risk of Mortality score. Crit Care Med 24:743-752
25. Inwald DP, Peters MJ, Walshe D, Jones A, Davies G, Klein NJ (2000) Absence of platelet CD40L identifies patients with X linked Hyper IgM syndrome. Clin Exp Immunol 120:499-502
26. Stenberg PE, McEver RP, Shuman MA, Jacques YV, Bainton DF (1985) A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 101:880-886
27. Nannizzi-Alaimo L, Rubenstein MH, Alves VL, Leong GY, Phillips DR, Gold HK (2002) Cardiopulmonary bypass induces release of soluble CD40 ligand. Circulation 105:2849-2854
28. Ahn ER, Lander G, Jy W, Bidot CJ, Jimenez JJ, Horstman LL, Ahn YS (2004) Differences of soluble CD40L in sera and plasma: implications on CD40L assay as a marker of thrombotic risk. Thromb Res 114:143-148
29. Kotowicz K, Dixon GL, Klein NJ, Peters MJ, Callard RE (2000) Biological function of CD40 on human endothelial cells: costimulation with CD40 ligand and interleukin-4 selectively induces expression of vascular cell adhesion molecule-1 and P-selectin resulting in preferential adhesion of lymphocytes. Immunology 100:441-448
30. Karmann K, Hughes CC, Schechner J, Fanslow WC, Pober JS (1995) CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci USA 92:4342-4346